Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJD6C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,058
Award facts
- Contract value 100% obligated
- $28,057.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,057.82 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be delivered to the company's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement across the Department of Defense and related healthcare systems. The company's extensive portfolio with DLA encompasses a broad range of pharmaceutical products and medical supplies, from specialty medications and brand-name drugs to vaccines and medical devices. This delivery order for Zepbound—a GLP-1 receptor agonist diabetes medication—exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare programs. As a prime contractor under the global pharmaceutical support vehicle, AmerisourceBergen demonstrates sustained capability to fulfill federal medical supply requirements through open competition and flexible contracting mechanisms.
Quick answers
Who was awarded contract SPE2DR26FJD6C?
SPE2DR26FJD6C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FJD6C worth?
The government has obligated $28,058 on SPE2DR26FJD6C.
Is contract SPE2DR26FJD6C an order under another contract?
Yes. SPE2DR26FJD6C is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJD6C competed?
The extent of competition for SPE2DR26FJD6C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award